Credit: eamesBot/Shutterstock

A research report from the EBRI Education and Research Fund found that employers will remove barriers to access certain procedures and medications designed to address chronic conditions when encouraged to do so by federal agencies. But that does not immediately translate into increased utilization by plan members.

EBRI decided to follow up on IRS Notice 2019-45. The notice gave permission to health savings account (HSA)-eligible health plans to cover, on a pre-deductible basis, 14 medications and other health services that were shown to effectively treat or manage chronic conditions. EBRI studied claims data between 2018 and 2021 to quantify the effect of expanding pre-deductible coverage.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Dan Cook

Dan Cook is a journalist and communications consultant based in Portland, OR. During his journalism career he has been a reporter and editor for a variety of media companies, including American Lawyer Media, BusinessWeek, Newhouse Newspapers, Knight-Ridder, Time Inc., and Reuters. He specializes in health care and insurance related coverage for BenefitsPRO.